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Abstract 
Neural stimulation is a powerful technique for modulating physiological functions and for writing 
information into the nervous system as part of brain-machine interfaces. Current clinically approved 
neural stimulators require batteries and are many cubic centimeters in size- typically much larger than 
their intended targets. We present a complete wireless neural stimulation system consisting of a 1.7 
mm3 wireless, batteryless, leadless implantable stimulator (the “mote”), an ultrasonic wireless link for 
power and bi-directional communication, and a hand-held external transceiver. The mote consists of a 
piezoceramic transducer, an energy storage capacitor, and a stimulator integrated circuit (IC). The IC 
harvests ultrasonic power with high efficiency, decodes stimulation parameter downlink data, and 
generates current-controlled stimulation pulses. Stimulation parameters are time-encoded on the fly 
through the wireless link rather than being programmed and stored on the mote, enabling complex 
stimulation protocols with high-temporal resolution and closed-loop capability while reducing power 
consumption and on-chip memory requirements. Uplink data indicates whether the mote is currently 
stimulating; it is encoded by the mote via backscatter modulation and is demodulated at the external 
transceiver. We show that the system operates at an acoustic power one fifth the FDA limit for 
diagnostic ultrasound and is robust to expected real-world acoustic link misalignment. We investigate 
the performance of the system with motes acutely implanted with a cuff on the sciatic nerve of 
anesthetized rats and show highly repeatable stimulation across a wide range of physiological 
responses. 
Extracellular electrophysiological stimulation is broadly applied to targets in the peripheral and central 
nervous system and has a long history of application both in neuroscience and clinical therapies. In the 
peripheral nervous system (PNS), the cochlear implant is well established for direct stimulation of 
auditory sensory afferents and the creation of useful auditory percepts. 1. More recent work has focused 
on creating devices that directly stimulate the PNS to regulate physiological functions2 such as 
modulating blood pressure3, rheumatoid arthritis4, incontinence5, sexual function6, and immune system 
function7; and directly writing neural codes to sensory afferents8 and motor efferents9. Electrical 
stimulation of central nervous system (CNS) targets is well-established for treatment of chronic pain10 
and central motor disorders such as tremor in Parkinson’s disease11 with deep-brain stimulation (DBS). 
Recent work shows promising results for treatment of depression12, modulation of decision making13, 
and use in closed-loop brain-machine interfacing14,15. 
The application of clinical neural stimulators is currently limited by implant size, implantation risk, 
and longevity of the device-tissue interface. Current clinically deployed neural stimulators have a 
volume greater than 6 cm3 16,17,18 and consequently must be placed in large anatomical pockets. These 
pockets can be far from the stimulation site (e.g., subclavical to subthalamic nucleus) or require 
removing substantial soft tissue or bone to form a pocket (e.g. Neuropace RNS18). Long leads are 
required from the stimulator housing to the stimulation site, which is a major source of infection, 
efficacy loss, and device failure19, in addition to electromagnetic interference, crosstalk, and power 
inefficiencies. Peripheral nerve cuffs which use wires to connect to a distant stimulator implant have 
shown detrimental effects on the nerve due to strain from the wire20,21, and fatigue and breakage in the 
lead22, emphasizing the benefit of a completely untethered device. A stimulator of a couple cubic 
millimeters in size, comparable to a grain of sand, could be entirely and independently placed directly 
at the site of stimulation. In comparison to traditional devices which require anatomical access or 
tunneling for a lead and an anatomical pocked for a relatively large can, this may improve the reward-
to-risk ratio of placing stimulators in certain anatomical locations, opening up new treatments and 
patient populations. A stimulator of a couple cubic millimeters in size or less, comparable to a grain of 
sand, could be placed directly at the stimulation site rather than requiring leads, thus improving safety 
and substantially increasing access to anatomical sites. A highly miniaturized stimulator would enable 
ultra-minimally-invasive delivery methods such as laparoscopy or injection, reducing tissue trauma 
during implantation and immune response23.  
A key challenge in developing wireless mm-scale stimulators is wireless power and communication 
that provides well-controlled, therapeutically relevant effects. Cochlear implant stimulators, have 
demonstrated wireless neural stimulation for decades24, but they are large (6 cm3) and operate only at 
shallow depth due to the use of an inductive link25,26. To date, the smallest volume stimulators have 
been implemented with passive components, providing inefficient voltage-mode stimulation that is 
sensitive to received power and electrode impedance27,28. Additionally, these stimulators do not have 
an uplink, preventing error detection or state monitoring via feedback to the external controller. Precise 
control of stimulation charge is important for targeting a repeatable population of cells and maintaining 
safety over chronic use. Neurostimulators employing integrated circuits can use active rectifiers to 
achieve a higher power conversion efficiency and deliver current stimulation that is independent of 
received power29,30,31. However, most active neurostimulators rely on a recovered clock from the high 
frequency wireless signal as well as programmed registers to generate stimulation waveform timing. 
Significant division of the recovered clock results in power overhead and programming large registers 
limits the dynamic programmability of the waveform. Furthermore, most of these wireless systems use 
electromagnetic (EM) waves for power delivery and communication, which couples inefficiently at 
centimeter scales deep within tissue 32.  
Recently, ultrasound has been proposed as an efficient way to power and communicate with mm-scale 
implants deep in tissue33, resulting in significant volume reduction for implants34,35,36,37. Compared to 
EM at 2 GHz, ultrasound energy at 2 MHz has less attenuation through tissue (1-2 dB/cm vs. 10-12 
dB/cm38), a higher FDA limit for power flux (7.2 mW/mm2 vs. 0.1 mW/mm2 39), and a smaller 
wavelength (0.75 mm vs. 25 mm) for more efficient coupling to small implants. 
Here, we present a system for wireless neural stimulation that employs 1.7 mm3 leadless, wireless 
“StimDust” stimulation motes. The ultrasonically powered StimDust motes contain a state-of-the-art 
custom integrated circuit (IC). A single link from a custom external transceiver to the mote provides 
power and bidirectional communication, reducing volume. A custom, time-coded wireless ultrasonic 
protocol dynamically sets stimulation waveforms, drastically reducing mote power consumption while 
maintaining a high degree of timing control.  
  Results 
  System Overview 
Fig. 1 | StimDust wireless neural stimulator system overview. a, Diagram depicting the StimDust system; here, it 
is used for stimulation of the sciatic nerve of a rat. b, The stimulating mote fully implanted and affixed to a rat sciatic 
nerve. Piezo at top, IC at bottom of mote. Stimulation pulses from the mote elicited compound action potentials in 
the nerve and compound muscle action potentials in the hindlimb musculature. c, Optional test leads on the mote were 
used for diagnostic and data reporting purposes to measure internal signals on the mote (also seen in (d)). They 
provided no power or control signals to the mote, and the mote function was verified with these leads disconnected 
from all external instrumentation. d, The wireless link traversed skin and muscle on top of a closed surgical site; this 
image shows the hindquarters of the animal superficial to the sciatic nerve. e, The external transceiver established an 
ultrasonic wireless link with the mote. The power and data cable is shown on the left and the external transducer is 
on the right. 
A conceptual overview of the StimDust system and its implementation is shown in Fig. 1. An external 
transceiver (Fig. 1e) established an ultrasonic wireless link through body tissue to an implanted 
StimDust mote (Fig. 1b, c). A single ultrasonic link provided both power to the mote and bidirectional 
communication. The mote consisted of a piezoceramic as the ultrasonic transducer; a custom IC (“Stim 
IC”) for power rectification, communication, and stimulation; a discrete capacitor for energy storage; 
bipolar stimulation electrodes; and a nerve cuff integrated on a thin polyimide printed circuit board 
(PCB). The mote was surgically implanted directly at the stimulation site, in this case the rat sciatic 
nerve (Fig. 1b), the wound was closed (Fig. 1d); the transcutaneous wires are optional test leads), and 
External 
transceiver
Ultrasonic 
wireless 
link
stim IC piezo
cuff
cap
Stim dust mote
1 mm
sciatic 
nerveelectrodes
a
e
c
b
1 cm
1 cm
d
1 mm
the external transceiver was coupled to the outside surface of the body with ultrasound gel. The system 
could produce a broad set of clinically relevant stimulation currents, pulse widths, and pulse repetition 
frequencies (PRF); these were sufficient to elicit highly repeatable compound action potentials (CAPs) 
in the sciatic nerve, compound muscle action potentials (CMAPs), and associated twitches in 
downstream muscles. 
Fig. 2 | StimDust system block diagram. The external transceiver is depicted on the left, the ultrasonic wireless link 
in the middle, and the StimDust mote on the right. left, The external transceiver consisted of a transmit (Tx) path (left-
top) which encoded user-specified stimulation parameters onto a 1.85 MHz carrier wave, stepped up the voltage, and 
drove an external piezo transducer during the Tx sequence. A receive (Rx) path (left-middle) was activated when the 
Tx was not active and captured and demodulated the ultrasonic backscatter. middle, The ultrasonic wireless link 
traversed the body tissue between the external transceiver and the implanted mote. The downlink provided power and 
time-delay coded stimulation commands for stim amplitude [A], stim pulse width [W], interphase gap duration [G], 
and electrode shorting duration [S]. The uplink consisted of backscatter amplitude modulation. right, The implanted 
mote harvested power and decoded stim parameters from the downlink. A finite state machine set stimulation 
parameters, initiated the specified stim pulse, and activated a modulation switch on the piezo input to change its 
ultrasound reflectance and encode a backscatter uplink bit indicating stim state information. 
A functional block diagram of the system is detailed in Fig. 2. The external transceiver40 (Fig. 4g) 
utilized a microcontroller to synthesize a low-voltage transmit signal, which encoded downlink 
stimulation parameters for each pulse onto a 1.85 MHz carrier. The low-voltage transmit signal from 
the microcontroller was stepped-up in voltage and drove the external piezoelectric ultrasound 
transducer. During the ‘off’ periods of the transmit signal, the external transceiver toggled from Tx 
(transmit) to Rx (receive) mode to capture and demodulate uplink data from the acoustic signal 
backscattered by the mote.  
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The implanted mote used an IC41 to rectify energy harvested by the mote’s piezo. Rectified energy was 
stored on an off-chip capacitor to ensure consistent operation of the IC during the ‘off’ cycles. The IC 
decoded received ultrasound to determine stimulation current amplitude (50 μA to 400 μA with 3b 
resolution), pulse width (450 ns resolution), interphase gap (450 ns resolution), post-stimulation 
electrode shorting phase (‘passive recharge’, 450 ns resolution), and PRF (0 – 5 kHz with 450 ns 
resolution). The mote delivered current-mode stimulation, during which the IC modulated the 
impedance across the piezo to change the amplitude of the reflected wave. This indicated to the external 
transceiver when the IC was stimulating and operating properly. 
Protocol and implant design 
The Stim IC timing diagram and architecture are shown in Fig. 3a, b. The IC used a custom ultrasound 
protocol, which enabled dynamically controlled stimulation waveforms and high system efficiency 
while maintaining a high degree of timing control. The protocol utilized the shape of the incoming 
ultrasound envelope to encode stimulation parameters, eliminating the need for an on-chip, 
continuously running clock to ensure timing precision. This reduced power consumption and afforded 
greater stimulation waveform timing flexibility compared to solutions that rely on a clock receiver, 
divider circuits, and on-chip registers to generate the stimulation waveform42,29.  
Fig. 3 | StimDust IC. a, The Stim IC timing diagram and b, architecture. Ultrasound from the external transducer 
charged VDD and the POR initialized the system. The watchdog detected ultrasound-free intervals and incremented 
the state. The amplitude was set by the duration of state A via a time-to-digital converter. Φstim enabled the stimulation 
current, Istim, and the modulation switch, Mmod. Backscattered ultrasound was detected by the external transducer 
during the ultrasound-free intervals. IC circuitry was heavily duty-cycled to conserve power. 
As shown in Fig. 3, an initial power-up sequence charged the implant’s storage capacitor, Cstore. As the 
supply voltage of the IC (VDD) ramped up to 2.5 V, a power-on-reset (POR) signal (threshold≈1.6 V) 
was generated to initialize the chip. If the POR signal was not generated, or VDD dropped below the 
threshold, the IC would not stimulate as a fail-safe against aberrant stimulation. In addition to the 
power-up sequence, the protocol was comprised of 4 repeating states: set amplitude (A), pulse width 
(W), interphase gap (G), and electrode shorting (S). Every state encoded information pertinent to the 
stimulation waveform interpreted by the IC and had a temporal resolution set by the carrier frequency 
(1/fcarrier = 540 ns). States A and G are called ultrasound-free intervals (UFI). A occurred during the 
first UFI and its duration encoded the stimulation amplitude. The watchdog timer circuit detected the 
UFI, which then triggered a 3-bit time-to-digital converter (TDC). The 3-bits of the TDC output were 
stored in memory for the stimulation pulse amplitude. W began when ultrasound returned and started 
a 16-cycle setup sequence to allow the current reference to settle prior to stimulation. On the 16th cycle, 
a current mirror whose amplitude was set by the TDC was enabled by the output of the counter, Φstim, 
causing the programmed current to flow from the stimulation electrode to the return electrode for a 
monophasic pulse. 
Stimulation was terminated at the second UFI. During G, the chip was in standby mode and the 
stimulation electrode was tri-stated to create an interphase gap. Interphase gaps have been shown to 
decrease stimulation thresholds in auditory nerves, motor nerves, and retinal ganglion cells, in addition 
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to decreasing perceptual thresholds in cochlear implant patients and epiretinal prosthesis 
patients43,44,45,46,47,48. State S started when ultrasound returned. During S, received ultrasound recharged 
the storage capacitor and the IC shorted the stimulation electrode to ground, clearing accumulated 
charge on the electrodes. Since the charge cleared quickly, monophasic stimulation with passive 
recharge49 was favorable to conventional biphasic stimulation since it consumes half the energy without 
limiting stimulation frequency in this work. Furthermore, biphasic stimulators typically use an 
additional shorting phase to clear residual charge that accumulates from phase mismatch50 (See 
Supplementary Information section 4 for further detail).  
Whenever ultrasound was on (W and S), a fraction of the incident ultrasonic energy was reflected to 
the external transceiver (backscatter). The backscatter amplitude was a function of the electrical load 
of the mote piezo. The delay between transceiver emission and backscatter detection was twice the 
acoustic time-of-flight (~20-60µs) between the external transducer and the mote piezo. During 
stimulation, a transistor switch, Mmod (Fig. 3b), was turned on to create a weak short (~4 kΩ) across the 
piezo terminals, reducing the amplitude of the backscatter signal (Supplementary Fig. 1). When Mmod 
was off, the electrical load impedance across the piezo ranged from 10 kΩ to 300 kΩ depending on the 
power consumption of the IC. The impedance change during stimulation provided a 1-bit data uplink 
and safety indicator, informing the external transducer when the mote was stimulating. 
Fig. 4 | StimDust fabrication. a, Mote IC die photo. b, Mote fabrication steps: (i) IC die was wire-bonded to mote 
flex substrate; (ii) discrete capacitor and piezo were bonded with silver epoxy and die was encapsulated with epoxy; 
(iii) piezo was wire-bonded; (iv) mote was encapsulated with parylene. c, Top view of mote: piezo on left, capacitor
at top, IC on right. d, Side view of mote: IC on left, capacitor and piezo on right. e, Underside view of mote: ground 
electrode on left, working electrode on right. f, Size comparison to US dime and g, a finger. h, External transceiver 
board. Data and power connection is on the left, microcontroller is under the passive heat sink, ultrasound interface 
chip is middle-right and transducer connector on the right. 
StimDust motes (Fig. 4) consisted of the IC, external storage capacitor, and a 750 µm x 750 µm x 750 
µm lead-zirconate titanate (PZT) piezoceramic transducer attached to a miniature flexible PCB and 
encapsulated with parylene. The piezo thickness was chosen such that the series resonance was at the 
carrier frequency of 1.85 MHz. This choice of thickness and carrier frequency was a trade-off between 
improving voltage harvest (larger thickness), lessening the effect of higher ultrasound attenuation at 
higher frequencies (lower carrier frequency), and reducing mote size (smaller thickness). The piezo 
thickness-to-width ratio (1:1) was a trade-off between improving current harvest (larger surface area), 
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minimizing mote size (smaller surface area), and increasing ultrasound acceptance angle (smaller 
aspect ratio). Stimulation electrodes located on the bottom of the PCB were electroplated with poly(3,4-
ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) to improve charge injection capacity 
and prevent compliance limiting when using the full current range of the chip. 
The StimDust stimulator was 1.7 ± 0.2 mm3 in volume. A cuff of 3.2 ± 0.4 mm3 volume was added to 
affix the stimulator to the nerve for in vivo validation. For comparison, current deep brain stimulation 
leads have an implanted volume of at least 88 mm3, with the tip and two most distal electrodes taking 
up a volume of at least 6.3 mm2 at the target stimulation site 51,52,53. A more aggressively scaled mote 
of 0.65 mm3 in volume was also designed (Supplementary Fig. 2) which used the same system 
architecture, piezo size, and fabrication techniques. A 5x higher current variant was also designed with 
the same footprint for applications with higher stimulation thresholds. The 1.7 mm3 mote design was 
used for all experiments reported in this paper, but the 0.65 mm3 mote design had no expected 
difference in performance. 
  Robust wireless operation in vitro and ex vivo 
Fig. 5 | StimDust performance in vitro. (a-f: performance in a gel tissue phantom; g: operation through ex-vivo 
porcine specimen) a, Mote waveforms recorded during a representative stimulation sequence where stimulation 
parameters were changed on-the-fly, demonstrating dynamic programmability. The first stimulation pulse of 150 μA 
for 37 μs was specified by regions A1, W1, and G1. The second stimulation pulse of 300 μA for 110 μs was specified 
by A2, W2, and G2. These two different dynamically-encoded pulses are less than 500 μs apart. b, Backscatter relative 
difference (see Methods) for 880 stimulation pulses. A population of successful stim pulses with backscatter values 
of ‘one’ bits was taken under good mote operating conditions with verified stim at the outputs. A population of 
backscatter samples with no stim and backscatter values of ‘zero’ bits was acquired by operating the mote in an 
underpowered state such that output stimulation was no longer performed. The two populations show good separation, 
enabling the use of backscatter as an indicator of successful stimulation. c, A mote was operated while its depth was 
scanned relative to a fixed external transducer acoustic field, yielding a viable region in depth. This was performed 
with the 25.4 mm diameter external transducer at 31.5 Vpk-pk transmit. d, e, f, A mote was operated within a fixed 
external transducer acoustic field while its position and orientation were scanned across transverse offset and angular 
offset relative to the mote central axis. Depth was held constant at 48 mm. d, Mote piezo harvest voltage. e, Mote 
regulated voltage. f, Mote able to stimulate region. g, Stimulation pulse while operating the mote at 55 mm depth 
through a fresh porcine specimen. The wireless link traversed approximately 1.5 mm skin, 1 mm fat, 47.5 mm muscle 
(gastrocnemius and soleus), and 5 mm gel. Stimulation at 400 μA for 392 μs drove a mock load (purely resistive) of 
3.3 kΩ. 
The error between specified current output and actual current output across all 8 amplitude levels (50 
μA to 400 μA) was 2.0% on average and 8.1% maximum (maximum absolute current error of 5.7 μA). 
The system achieved up to 2.38 kHz pulse repetition frequency (PRF) while stimulating with a pulse 
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width of 80 μs at 400 μA and minimal compliance limiting. A PRF of 5.05 kHz was achieved with 50 
μA current and 80 μs pulse width. Higher frequencies resulted in a VDD droop and compliance-limited 
current output, though absolute maximum PRF was 16 kHz. Piezo impedance modulation via the Mmod 
switch for uplink data modulation showed a drastic amplitude change in VPz+ (Fig. 5a). At the external 
transceiver, the actual uplink bit error rate (BER) (Fig. 5b) was 0 out of 880 and the estimated Gaussian 
fit BER was 9.9 x 10-8 (with the threshold set to minimize BER). 
While keeping derated ISPTA at the FDA limit, a mote operating in a gel tissue phantom achieved: 
stimulation power of 89 μW (23 nC and 37 nJ per pulse at 2380 Hz), power transfer efficiency from 
acoustic power at the face of the mote to usable electrical power in the mote of 3.4%, and power transfer 
efficiency from acoustic power at the external transducer to electrical power in the mote of 0.7% 
(Supplementary Section 1 and Supplementary Table 1: include detailed analysis of wireless link 
efficiencies for operation in a tissue phantom and operation in vivo). 
The use of an ultrasonic link over an EM one was crucial for achieving high link efficiencies at sub-
mm transducer sizes and cm-depths in tissue. An important consideration for the practical deployment 
of such a system is understanding the effect of acoustic link alignment. The StimDust system could 
reliably operate when the mote was shallower than 66 mm (70 mm absolute maximum operational 
depth observed), when the incident ultrasound was within ±25° of the mote central axis, and when the 
external beam was centered within a 2.2 mm range around the mote position (Fig. 5c-f). Depth and 
lateral alignment of the mote within the external transceiver acoustic beam were easily controlled by 
adjusting the position, angle and skin-offset of the external transceiver. The mote’s precise angular 
orientation within the tissue, on the other hand, was difficult to measure, constrain, and control after 
implantation; the relatively wide ±25° acceptance angle enabled a robust acoustic link despite this fact.  
The device was operated wirelessly at 55 mm depth through ex vivo porcine tissue to assess 
performance at moderate-depth in real tissue. The acoustic field (570 mW derated ISPTA) supplied 19.4 
mW Pacoustic at the skin and passed through approximately 1.5 mm skin, 1 mm fat, 47.5 mm muscle, 
and 5 mm gel. The mote generated 65 μW Pelectrical at VDD, yielding a power transfer efficiency from 
acoustic power at the skin to electrical power in the mote of 0.33%. Stimulation was possible at all 
parameters up to 400 μA current and 1500 μs duration.  
The minimum acoustic field peak intensity under which the mote could power up and stimulate was 
142 mW/cm2 derated ISPTA with a mechanical index of 0.049 (pressure amplitude of 66.1 kPa), 20% 
and 2.6%, respectively, of the FDA limits for diagnostic ultrasound39. Thus, anywhere in the body that 
ultrasound at 142 mW/cm2 can be safely delivered (acoustic intensity below 720 mW/cm2 at all points 
in acoustic field), StimDust mote will operate. With the 25.4 mm diameter external transducer used in 
this study, the maximum depth of operation in homogeneous fat, liver, and muscle tissue (1.1 dB/cm, 
1.78 dB/cm, 2.2 dB/cm attenuation, respectively, at 1.85 MHz54,55), is estimated to be 62 mm, 56 mm, 
and 51 mm, respectively (Fig S3). An external transducer with a longer focal length and wider aperture 
could be used to substantially improve maximum depth of operation while maintaining peak acoustic 
intensity at safe levels. Such longer focal-length transducers56,57 would be able to operate a mote near 
140 mm of depth. 
Precise stimulation in vivo 
Fig. 6 | In vivo performance: mote, backscatter, and evoked neural response waveforms for fully-implanted 
mote. a, A stimulation pulse from the mote (a top) elicited a compound muscle action potential (a bottom). b, Detail 
of stimulation pulse signals. The downlink code regions A1, W1, and G1 specify the stimulation pulse. During S0 the 
ultrasound envelope was high (Vpz+), the charge in the energy storage capacitor was topped off (VDD), and the 
electrodes were shorted (Velec). [1] The external interrogator set the downlink ultrasound envelope from on to off, and 
after a short delay, began to capture the backscatter signal xS,0 from the mote from the S0 period ((b), middle). [2] One 
acoustic time-of-flight (TOF, approximately 16.9 µs in this trial) later the mote saw a transition from S0 to A1, 
beginning the first UFI (ultrasound free interval) and initiating the current amplitude TDC decoder. [3] One TOF after 
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the mote S0 to A1 transition, the primary backscatter from the mote S0 region as seen at the external transducer ceased 
((d), orange line). [5] At the mote A1 to W1 transition, the stimulation amplitude was set, and a header / setup sequence 
lasted for 16 ultrasound cycles (c), after which [6] the stimulation output pulse began and Mmod turned on, reducing 
the amplitude of VPz+/-. During stimulation, the voltage measured at the stimulation electrodes showed an immediate 
IstimꞏRsoln increase, and then gradually increased due to charging of the double layer capacitance. VDD dropped linearly 
during this period due to constant current flow through the stimulation electrodes. In addition, there was an electrical 
stimulation artifact on the EMG signal during the stimulation event ((b), bottom). [7] The external transceiver began 
the second UFI and after a short delay, began to capture the backscatter signal xW,1 from the mote from the W1 period 
((b), middle). [8] At the mote W1 to G1 transition, the stimulation electrodes were set to high impedance for the 
interphase gap. The electrode voltage showed an immediate IstimꞏRsoln drop and then a RsolnꞏCdl discharge as the 
double-layer capacitance discharged. [9] One TOF later the primary backscatter seen at the external transceiver from 
the W1 period ceased ((d), black line). [11] At the mote G1 to S1 transition, the stimulation electrodes were shorted to 
discharge any remaining charge. [12] The stimulation pulse produced by this sequence of events evoked the compound 
muscle action potential seen in (a, bottom). d, Detail of backscatter signal captured at external transceiver, showing 
amplitude modulation. e, The two regions from (d) were compared to yield 111 ‘one’ bits, with good separation from 
111 ‘zero’ bits (grey line depicts threshold). f, Initial charge-up of the 4 μF Cstore after the mote had been without 
power for 4.2 seconds and VDD had drained to 0.7 V. g, High pulse repetition frequency in-vivo stimulation. The small 
electrode voltage rise which precedes the main ohmic rise in each of these pulses is due to the remaining charge on 
the simulation electrodes from the previous stimulation pulse which was not fully cleared during relatively brief ~230 
μs shorting phase. Note: data in panels (a-e) are from the same stimulation parameters condition during a single in 
vivo experiment with a fully implanted mote (animal D). Data in panel (f) is from in vivo fully-implanted mote (animal 
D). Data in panel (g) is from in vivo while taking data with an open surgical site (animal A). 
In vivo stimulation elicited robust and repeatable compound action potentials. Stimulation in an acute 
preparation was demonstrated in six animals and data is presented for animals D (Figs. 6, 7, S5), C 
(Fig. S6), and F (Fig. S6). The motes implanted in animals C and D had overlaying muscle and skin 
layers replaced and sutured after implantation and were operated with the ultrasonic link traversing 
these tissue layers (Fig. 6, Fig. S6, Supplementary Video 1). The acoustic field (Supplementary Fig. 3) 
had a derated ISPPA and ISPTA of 713 mW/cm2 and mechanical index of 0.11, both below the FDA limits 
of 720 mW/cm2 and 1.9, respectively, for ultrasound diagnostic imaging39, and lower than thresholds 
for directly ultrasound-mediated stimulation (Supplementary Section 2). Fig. 7a-d shows all signals of 
interest during a stimulation pulse while a fully implanted mote was operated through skin and muscle 
layers. The downlink commands received by the mote, S0, A1, W1, G1, S1, can be seen in the VPz+ trace 
in figure 7(b), top. The conduction delay between stimulation and evoked CMAP of approximately 1.5 
ms corresponded to the expected conduction velocity of approximately 25 m/s58 and distance of 
approximately 30 mm. Through-tissue backscatter uplink performance (Fig. 6d, e) had an actual BER 
of 0 out of 222 and a Gaussian fit estimated BER of 1.5 x 10-7. This indicated a robust 1-bit data uplink 
that could reliably report the success of each pulse to the user.  
  Stimulation parameters control physiological response 
Fig. 7 | Precise control of evoked neural response achieved through varying stimulation current or stimulation 
pulse width. [Current-control]: Stimulation current was varied from 50 μA to 400 μA with stimulation pulse width 
held at 392 μs. a, Stimulation electrode voltage shows an approximately linear trend with stimulation current. b, 
CMAP (compound muscle action potential) waveforms show activation for 250 μA to 400 μA. For each condition, 
the colored line represents the trial-average CMAP voltage at each point in time, the width of the shaded error region 
is ± 1σ, and N is the number of pulse events in each condition. c, CMAP amplitude vs. stim current shows a typical 
sigmoidal recruitment curve. Each point is a single CMAP baseline-to-peak amplitude, the line is a sigmoidal fit and 
error bars are ± 1σ for the CMAP’s each condition. [Pulse-width-control]: Stimulation pulse width was varied from 
12 μs to 392 μs with stimulation current held at 400 μA. d, Stimulation electrode voltage show similar dynamics for 
increasing stimulation pulse width. e, CMAP waveforms show activation from 42 μs to 392 μs. For each condition, 
the line represents the trial-average CMAP voltage at each point in time, and the width of the shaded error region is 
± 1σ, and N is the number of pulse events in each condition. This panel shows that the duration of the electrical artifact 
increased with increasing stimulation pulse width, but the time-course of the CMAP did not appreciably change, with 
only amplitude differing. f, CMAP amplitude vs. stim pulse width shows a typical sigmoidal recruitment curve with 
little or no evoked response below 22 μs pulse width and saturation at approximately 140 μs pulse width. Each point 
is a single CMAP baseline-to-peak amplitude, the line is a sigmoidal fit and error bars are ± 1σ for the CMAP’s in 
each condition. Note: This data was taken with an open surgical site. 
In vivo EMG response was controlled by varying stimulation current from 50 µA to 400 µA with fixed 
392 µs pulse width (Fig. 7a-c). The low standard deviation of the CMAP waveforms (line width in Fig. 
7a, d) indicated highly repeatable stimulation and biological response across pulses. The recruitment 
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curve as a function of stimulation current (Fig. 7c) showed a threshold of activation between 200 µA 
and 250 µA and saturation between 350 µA and 400 µA. The CMAP amplitude saturated at 4.4 mV. 
In vivo EMG response was also controlled by varying stimulation pulse width with fixed 400 µA 
current (Fig. 7d-f). The CMAP amplitude response showed the duration-threshold of elicitation of 
action potential at 400 μA current to be approximately 26 μs, with response saturation around 150 μs 
and maximum CMAP amplitude of 4.2 mV. 
A second set of current-control and pulse-width-control sweeps were performed two hours after the 
first (Supplementary Fig. 5). Wireless link performance, communications, and stimulation output were 
unchanged. The biological response was very similar but showed recruitment curves shifted slightly 
left, indicating a 15% reduced threshold of recruitment, and 11% lower CMAP amplitude saturation. 
These slight differences were potentially due to impedance changes at the electrodes and excitability 
in the nerve as the tissue began to responds to the implant, muscle fatigue (though pulse repetition 
frequency was low), or changes in the plane of anesthesia. 
Measurement of CMAPs from multiple innervated muscles in animal F (Fig S6) (the medial and lateral 
heads of the gastrocnemius, and the tibialis cranialis) show strong co-activation of muscle groups, 
indicating that stimulation was delivered to multiple fascicles in the nerve. 
In vivo stimulation across pulse repetition frequencies from 0.22 Hz to 2.22 kHz yielded four regimes 
of muscle activation. Pulse width and current were fixed at 52 μs and 400 μA. By visually observing 
muscle twitch response, we qualitatively reported single twitches at 0.25, 0.33, 1, 2, 5, and 10 Hz, 
unfused tetanus at 32 Hz, and fused tetanus at 100 and 320 Hz. This matched expected muscle responses 
for rat gastrocnemius59. At 2 kHz and 2.22 kHz (Fig. 6g), we observed a single initial twitch and then 
apparent relaxation. While we did not measure muscle force in this study and thus could not positively 
confirm nerve block, nerve block has been reported at 2 kHz stimulation frequency and 1 V drive 
voltage (approximately 666 μA)60. Therefore, while not conclusive, these observations were consistent 
with the system performing nerve block.  
With stimulation and return electrodes each sized 550 μm x 550 μm, the voltage drop across the 
spreading resistance, also known as access voltage, (IstimꞏRsoln ≈ 1.7V) accounted for a majority of the 
stimulator headroom. This allocated approximately 0.6V of headroom across each electrode interface 
and kept the electrodes safely operating within the electrochemical water window of PEDOT:PSS (-
0.6V to 0.8V). While asymmetric electrodes could utilize the entirety of the water window during the 
stimulation phase by preferentially charging stimulation electrode to a higher voltage (return electrode 
larger than stimulation electrode), we opted to use symmetric electrodes since the voltage on the 
stimulation electrode is inverted during the shorting phase. The maximum combined interfacial 
potential was considered to be voltage across the stimulation electrodes 20 µs into the interphase gap61 
(gray arrows in Fig 7a,d). This value was below 1.23 V under all stimulation pulse conditions less than 
400 µA current and 392 µs pulse duration (the maximum conditions tested). At this maximum corner-
case, the maximum combined interfacial potential was between 1.31 and 1.36 V. This is slightly above 
the maximum range, but this corner-case condition can be avoided while still accessing the full 
recruitment curves. And minor overpotential at or above this corner-case would be very small and only 
last a few tens of µs. Furthermore, the two electrodes were in close proximity, enabling rapid aqueous 
diffusion and recombination of any potential reaction products above this stimulation level. Finally, an 
updated design of StimDust could increase electrode area marginally to mitigate any overpotential. 
Discussion 
Our results indicated that repeatable, controlled compound action potentials can be elicited by the 
StimDust system in an acute preparation. Grading the physiological response through controlling 
stimulation current, pulse-width, and pulse repetition frequency demonstrated efficacy for a wide range 
of stimulation techniques and is an important component of safety. Furthermore, miniaturization of the 
precision stimulator enabled placement directly at the stimulation site on the sciatic nerve. 
  Table 1: State-of-the-art comparisons table 
Table 1 summarizes the performance of StimDust and compares it with state-of-the-art implantable 
wireless neural stimulators37,36,27,30,28,62.  Wireless ultrasonic power and data delivery enabled implant 
operation at a depth of 70 mm in ultrasound gel. Additionally, direct control of the stimulation 
waveform by the received ultrasound boasted several advantages over state-of-the-art. Compared to 
systems that program motes via a bitstream, StimDust achieved sub-µs (1/fcarrier) temporal resolution 
with a larger dynamic range for pulse width, interphase gap, and PRF because the complexity was 
pushed to the external transceiver, which had fewer computational and power constraints. Stimulators 
which used only passive components27,28 used a direct control scheme as well; however, the stimulation 
intensity was dictated by the received power and the output was voltage stimulation which is sensitive 
to electrode properties. Furthermore, they did not feature an uplink whereas StimDust included a 
wireless uplink via ultrasonic backscatter for safety monitoring and alignment. Active rectification 
increased efficiency and established a ground reference potential, enabling StimDust to use passive 
recharge to save power relative to biphasic stimulation while clearing residual stimulation charge on 
the electrodes, which other direct control systems27,28 were unable to do. Using an enable signal, or 
TBioCAS '18 TCAS II '13 PLOS ONE '17 Sci. Reports '18 Front. Neuro. '17 TBioCAS '18
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StimDust
This Work
Stim. type current current voltage current voltage current current
Link ultrasound ultrasound RF 4 coil inductive RF RF ultrasound
fcarrier [MHz] 1.3 1 2400 13.56 10 1300 1.85
Uplink none none none 433 MHz OOK none none backscatter
Process [nm] 180HV 350 discrete 130 discrete 130 65
Waveform configuration digital bitstream digital bitstream received power digital bitstream received power received power envelope detection
FStim [Hz] / resol. [bit] 0 - 60 60 - 265 /2b 0 - 25* 13-414 /5b 2* 0 - 3* 0 - 5k**
Stim start enable signal -- received power stim command received power received power enable signal
TPulse resolution [us] 14 / 5b 200 / fixed continuous 9.5 / 5b continuous continuous continuous
IStim,max [µA] / resol. [bit] 5000 / 8b 640 / 5b undefined 1860 / 5b undefined 25 / fixed 400 / 3b
Tgap resolution [µs] 1/2 Tpulse -- N/A 9.5 / 5b N/A N/A continuous
Charge balance biphasic/gnd dc-blocking cap none passive recharge
Compliance voltage (V) 15 3.3 N/A 2 N/A 1.2 3
pig vagus rat sciatic rat sciatic
Fully-implanted no no yes yes yes no yes
in-vitro depthtx-rx [mm] 105 (castor oil) -- -- -- -- 5 70 (gel), 55 (muscle)
in-vivo depthtx-rx [mm] -- 50 15 -- 50 -- 18
Mass [mg] 78 -- 300 2800 -- -- 6.4
Circuit η (Pstim/Pin) [%] <50 -- 20 -- -- -- 82
Volume [mm3] 39 1020 40.5† 2250 0.45‡ -- 1.7 ‡
Electrodes [mm]
0.5Ø x 2.0 Pt 
cylinder
-- 2.7Ø x 1.0 Pt cuff cuff 0.3Ø Pt disk 0.125Ø SS disk 
on cuff
0.55 PEDOT square
Implant encapsulation PDMS -- epoxy epoxy & PDMS epoxy -- parylene
FOM (Depth/Volume) 2.69 0.05 0.37 -- 111.11 -- 32 §
FOM (Volume/Efficiency) 0.78 -- 2.03 -- -- -- 0.02
*demonstrated, range not provided
†estimated
**up to 16kHz in burst
‡includes stim electrodes but not cuff
Animal model ex-vivo frog sciatic   rat abdomen
none       3b biphasic correction       n ne
      rat sciatic      x-vivo rat sciatic
stimulation start command, allowed the mote to stimulate with low latency, which is crucial for closed-
loop experimentation. 
In addition to highly programmable stimulation, StimDust was also the smallest neural stimulator with 
precise current-control output. The efficient integration and co-design of the piezoceramic, Stim IC, 
storage capacitor, and interface electrodes enabled miniaturization of the mote down to 1.7 mm3 in 
volume and 6.4 mg. This represents >10x improvement in depth/volume figure of merit (FoM) and 
>25x improvement in volume/efficiency FoM relative to other state-of-the-art precision neural
stimulators. A further-miniaturized revised StimDust design yielded a mote volume of 0.65 mm3 and 
expected depth/volume FoM of 78 mm-2, a >29x improvement over state-of-the-art. 
The use of ultrasound as the wireless power carrier enabled direct voltage harvest from the mote piezo 
of up to ~7 Vpk-pk and ~3.5 V rectified under safe ultrasound intensity levels, which is sufficient for 
stimulation with low-impedance electrodes. We chose to take advantage of this to optimize for high 
power-efficiency rectification. While operating at clinically relevant depths of multiple centimeters, 
this enabled our high PRF (and high total Pstimulation), which is important for some clinical use cases 
such as nerve block. The acoustic-to-electrical power conversion could have alternatively been 
optimized for voltage efficiency rather than power efficiency which would have enabled greater depth 
of operation or a thinner piezo (both of which reduce mote piezo voltage) at the expense of maximum 
PRF and Pstimulation.  
The StimDust platform can be modified and extended to suit various applications 
The demonstration of the StimDust stimulator in this work was carried out on a peripheral nerve while 
utilizing a simple cuff-type nerve attachment most similar to a split-cylinder style cuff. Translation to 
other stimulation targets and devices with modified morphologies is a ready possibility. For example, 
with modification to electrode feed-throughs or vias, the StimDust simulator could be attached to a 
self-sizing spiral cuff63,64 or helix-style cuff65,66 which have shown safer levels nerve pressure over a 
wider range of nerve diameters, increasing safety against nerve damage. Furthermore, if fiber-tract 
specificity is critical for the clinical use case, the StimDust stimulator could be paired with cuff and 
electrode styles which achieve specificity, such as a multi-contact cylindrical cuff device64, a FINE-
style cuff67,68, sieve electrodes69 or intrafascicular electrodes70,71. While no nerve pressure or strain 
measurements were taken as part of this study, it is expected that an implementation of StimDust with 
any cuff style that is completely wireless, tethereless, and leadless, will reduce the incidence of lead-
induced strain on the nerve, especially in areas of high motion such as joints. 
For certain applications, such as producing differentiated percepts in artificial sensory stimulation8 or 
increasing input dimensionality15, stimulating at multiple sites is an important capability. This could 
be achieved with StimDust with multiple independent motes or multiple stimulators attached to a single 
cuff-like device. These motes would be operated with independent ultrasonic links, generated by 
independent external transceivers or a single external transceiver with an array transducer. In the 
present design, the ultrasonic link is an approximately gaussian beam with a full-width-half-maximum 
of 1.6 mm in the focal plane (Fig S3). Thus, two stimulators separated by approximately 2 mm or more 
would be able to be operated independently. Alternatively, a revised StimDust design could incorporate 
multiplexing into the Stim IC without additional external components. This requires a modification of 
the communication protocol to select the source and sink electrodes for the stimulation pulse. This 
multiplexing strategy when combined with the previously multi-mote method, drastically increases the 
number of stimulation sites. 
An important use case for a wireless neural stimulator is placing the mote in the brain for use in DBS 
and brain-machine interfacing. The diminished size, potential for ultra-minimally invasive delivery, 
and totally wireless operation opens up possibilities such as wireless multi-site deep brain stimulation 
and cortical stimulation for proprioceptive feedback. If a small and wireless stimulator is shown to have 
lower risk in chronic clinical settings, then the risk-threshold for neurostimulation will be lowered, 
enabling it’s use in a wider set of indications such as certain psychiatric conditions12,13. Intracranial 
use-cases pose a new challenge, though: establishing an ultrasonic power and communications link 
through the skull is challenging due to the greater attenuation in skull than in soft tissues. Transcranial 
ultrasound has been shown to safely achieve ultrasonic power levels in the brain of 159 mW/cm2 at 2 
MHz and a focal depth of 4.5 cm72,73. StimDust is able to operate at a power level (142 mW/cm2) and 
frequency (1.85 MHz) lower than this, indicating potential applicability to transcranial and deep-brain 
operation. 
Clinical Translation 
In order to clinically translate StimDust for chronic use cases, long-term performance over a 
meaningful treatment period must be demonstrated. To achieve device lifetimes longer than several 
months to a few years, the parylene encapsulation used for StimDust in this work can be replaced with 
device packaging or encapsulation with greater hermeticity. Ceramic and metallic packages have been 
shown to provide excellent hermiticity and can scale down to millimeters74,75,76. Recently, an alumina-
titanium package was used to house an acoustically powered IC, and both ultrasonic powering and 
backscatter communication were demonstrated through the sealed package77. This package had wall-
thicknesses of 250 μm. Thus, using proven processes and materials, the StimDust stimulator could be 
packaged while only increasing dimensions by approximately 0.5 mm in width, height, and thickness. 
In addition, inert conformal thin-film coatings are a promising method of providing hermetic 
encapsulation without significantly increasing the volume of the device. 1-μm-thick silicon dioxide 
device encapsulation78 has been shown to provide a barrier for electronics in the biological environment 
for a projected 70 years. Silicon carbide encapsulation79 has shown even greater longevity, and has an 
encapsulation thickness of 550 nm to 1000 nm. Silicon carbide can also be doped to create conductive 
electrode sites, obviating electrode pass-throughs and material interfaces for crack nucleation or water 
vapor permeation. It is important to note that non-toxic piezoelectric materials, such as barium titanate80 
can be used in place of PZT, with a reduction in acoustic power harvesting of approximately 27%81. 
The StimDust design in this work used PEDOT plating on the gold electrodes to improve charge 
injection capacity and enable small electrodes82. PEDOT coatings on smooth metallic substrates can 
delaminate after approximately a year in the biological environment83. To achieve comparable 
stimulation performance with clinically-proven long-lasting electrode materials, StimDust can use 
electrodes with larger area. The reported device had an electrode area of 0.303 mm2 and demonstrated 
a charge injection limit of 137 nC ph-1 in vivo. The electrode area can be increased to 2.5 mm2 within 
the existing footprint of the StimDust substrate board, and electrode area can be increased by to 5.0 
mm2 if the electrodes use the inside surface of a 1.2 mm diameter cuff. A 2.5 mm2 Pt or PtIr electrode 
has an estimated charge injection limit in the range of 415 nC to 2850 nC 84,85, substantially more than 
what was needed during the in vivo experiments performed with StimDust. Clinically approved 
stimulators use smooth PtIr electrodes of approximately this area: the Cyberonics Helix electrode, used 
clinically for vagus nerve stimulation, has electrodes with area estimated to be 3.1 mm2 each86,87 and 
the Boston Scientific directional DBS lead utilizes PtIr electrodes of approximately 2 mm2 area88.  
Various techniques and materials have shown that higher charge injection capacity electrode materials 
can be fabricated that have good longevity. This includes Electrodeposited Platinum-Iridium Coating 
(EP-IC)89 which is a mechanically robust coating that has demonstrated at least 180-day lifetime in 
vivo and 10-years-equivalent in vitro testing. Platinum black and platinum grass90 show lower 
impedance than smooth platinum. Use of PEDOT in a chronic device may be possible by roughening 
of the metallic layer that PEDOT adheres to91,92.  
Scar tissue can create a sheath of fibrous tissue around the implant. Fibrous tissue, such as cartilage 
and tendon, can have acoustic impedances slightly higher than that of water and most other tissues93 
leading to an acoustic boundary and a reduction in mote power of approximately 0.23%, a small to 
negligible impact on the performance of the ultrasonic link. The fibrous encapsulation can also have 
an effect on the impedance of the tissue. Pt-Ir cuff electrodes measured over 70 days on the cat sciatic 
nerve94 have been shown to have a 1000-Hz impedance stabilize at approximately 150% that of its 
initial value. Another study, measured the resistivity of fibrous encapsulation in cats95 and reported that 
implanted platinum electrodes showed a tissue resistivity drop during days 0 to 4 post-implantation 
followed by a rise to 60% of its initial value. This indicates that StimDust should be able to perform 
safe and efficacious stimulation even after a drift of ± 50% from the nominal impedance at 
implantation. The potential for a 50% increase in tissue impedance can be accommodated by the 
presented StimDust design by increasing the electrode area. 
A clinically translated StimDust device with these longevity solutions is predicted to have in vivo 
durability that exceeds that of current clinical devices due to the absence of critical failure modes. 
Traditional implantable neural stimulator failures are dominated by lead failures, reported to occur in  
7.6% 96, 2.9% 97, and 1% 98 of implantations. This can occur through fatigue failure of bending 
components or at the lead feedthrough to the stimulator99. Leaded simulators are typically implanted 
as separate components and rely on a lead-feedthrough connection that is made intraoperatively. 
StimDust can be hermetically sealed and quality-controlled in manufacturing, and is implanted as a 
single monolithic device. 
In conclusion, we have introduced the smallest wireless neural stimulator that can deliver current-
controlled stimulation. Compact mote integration and programmable stimulation was enabled by a 
custom wireless ultrasound protocol and an energy efficient integrated circuit. We demonstrated its use 
acutely implanted in anesthetized rats to controllably elicit compound action potentials across a range 
of clinically relevant stimulation regimes. Taken together, this work shows a practical demonstration 
of a stimulator for the PNS with potential applicability to the CNS. We anticipate the introduction of a 
new class of neural stimulators that are small enough to be deployed en masse with low risk to the 
patient, and which open up new and powerful therapeutic and neural interface techniques.  
Methods 
Design, fabrication, and assembly of the StimDust motes: The StimDust motes were built on 
a 100 µm thick, polyimide, flexible PCB (Altaflex, Santa Clara, CA). Polyimide substrates were 
preferable to FR-4 substrates due to their higher thermal budget, superior chemical compatibility with 
organic solvents, and higher flexibility of the substrate, facilitating device testing and in vivo 
implantation.  
Stimulation electrodes were located on the underside of the PCB. The electrodes had 0.55 mm x 0.55 
mm dimensions with 1 mm center-to-center spacing. To prevent compliance limiting when using the 
full current range of the chip, the electrode impedances were designed to be < 6.25 kΩ at the stimulation 
pulse frequency (~2.5 kHz for a pulse width of 200 µs – the lowest frequency used and therefore highest 
impedance). The impedance of the gold electrodes on the PCB was lowered by electroplating poly(3,4-
ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) using a NanoZ impedance testing and 
electroplating device (White Matter LLC, Mercer Island, WA). The nominal plating current was 
approximately 4 µA/mm2 for 60 s in a plating solution of 1:1 ratio 0.02 M EDOT and 0.2 M PSS. In 
recent work, PEDOT:PSS has demonstrated a charge injection limit 15x that of PtIr and IrOx electrodes 
and >3x reduction in the voltage transient82. The impedance of the gold stimulation electrodes was 
characterized in 1x phosphate buffered saline (PBS) using a NanoZ before and after PEDOT plating 
and again after full assembly of the motes. One electrode served as the active electrode while the other 
served as the reference electrode. A frequency sweep between 1 Hz and 5.02 kHz was performed and 
the impedance data collected (Fig S7g), yielding an impedance of approximately 2 kΩ at 2 kHz41, down 
from approximately 9 kΩ before PEDOT plating. The electrode stimulation voltages were 
characterized in PBS with relevant pulse currents and durations both before and after PEDOT plating 
(Fig S7a-f). The charge injection capacity (measured across both electrodes) of the gold electrodes was 
19 ± 5.1 µC ꞏ cm-2 ꞏ ph-1 (N=3) and of the PEDOT electrodes was 188 ± 61 µC ꞏ cm-2 ꞏ ph-1 (N=3). The 
charge injection capacity of the PEDOT electrodes adjacent to the sciatic nerve in vivo was 45 µC ꞏ 
cm-2 ꞏ ph-1 (N=1).
Following electroplating, the IC was attached to the PCB using a conductive silver epoxy (H20E, 
Epoxy Technology Inc., Billerica, MA) (Fig. 4b) and cured at 150 °C for 10 minutes. The IC and PCB 
were then cleaned in acetone, followed by isopropyl alcohol and DI water to clean the device prior to 
wirebonding. The IC was wirebonded to the PCB using an ultrasonic wedge wirebonder (7400B, West 
Bond, Scotts Valley, CA) and potted in UV-curable epoxy (AA 3526, Loctite, Düsseldorf, Germany) 
to protect the wirebonds. 
Next, a 750 µm x 750 µm x 750 µm lead-zirconate titanate (PZT) cube (841, APC Int., Mackeyville, 
PA) and an 0201 surface mount capacitor for charge storage were attached to the PCB using silver 
epoxy and cured at 150 °C for 10 minutes. PZT was chosen for its high electromechaincal coupling 
constant and relatively low loss tangent enabling good voltage and power harvest in semi-continuous-
wave applications. Barium titanate piezoceramic could also be used for improved biocompatibility, but 
with a slight reduction in electromechanical coupling coefficient. The PZT coupon was diced from a 
750 µm thick sheet of PZT, premetallized with 12 µm of fired-on silver, using a wafer-dicing saw with 
a ceramic-cutting blade. To complete the circuit, the top terminal of the PZT coupon was wirebonded 
to the PCB. 
The devices were then coated with roughly 10 µm of parylene-C for insulation using chemical vapor 
deposition (Specialty Coating Systems, Indianapolis, IN). No adhesion promoter was used. Parylene 
was chosen as the insulation material due to its excellent properties as a moisture and chemical 
barrier100. Furthermore, because parylene can be precisely deposited with thicknesses on the order of 
microns, it does not damp the vibrations of the piezoceramic as strongly as other insulation materials 
such as polydimethylsiloxane (PDMS) or epoxy, allowing for higher efficiency power harvesting. The 
stimulation electrodes were exposed by gently scoring the parylene around the electrodes using a 
tungsten probe tip and peeling the parylene away. The parylene encapsulation used in this work is 
expected to last from several months to a few years in the biological environment101. Implementation 
of recent advances for long-term conformal encapsulation for mm-scale implantable devices could 
enable decades- or lifetime-longevity78,79. 
To aid in surgical placement of the mote on the rat sciatic nerve, a cuff was affixed to the back of the 
mote. The cuff was made by cutting a small piece of silicone tubing (0.8 mm ID, 1.6 mm OD) to 
roughly the length of the mote. The tubing was then cut in half and attached next to the electrodes using 
UV-curable epoxy and silicone adhesive. 
The volume of the mote stimulator and the combined stimulator and cuff were measured via measuring 
fluid displacement. To achieve high accuracy, the mass of displaced fluid was measured and volume 
calculated from the density of the working fluid. This was performed by dropping the device into a 
container with working fluid on a scale. The object became submersed in the fluid, but was suspended 
on a wire mesh supported off of the scale. Thus, the buoyant reaction force was measured by the scale, 
but not the total mass of the object. A single stimulator and cuff were, each separately, measured 7 
times. The measurement range of volume measurements was reported at 4 times the standard deviation 
of measurement values observed to take into account additional bias and variance from scale readings, 
liquid density uncertainty, liquid evaporation, and small volume differences device-to-device. 
A further-miniaturized revision of the StimDust mote was also designed (Supplementary Fig. 2). For 
this design, an IC was fabricated with its size reduced by removing unnecessary test circuits and debug 
pads and using pad-over-circuit. Additional size reduction in the mote design came from the use of a 
0.5 mm x 0.25 mm footprint storage capacitor and refinement of component and wirebond placement. 
While this smaller design was not used for the experiments reported in this paper, it did achieve a 
volume of 0.65 mm3 with maximal dimensions of 1.17 mm length, 0.77 mm width, 0.89 mm height 
(estimated from 3D model). This design is substantially smaller than the tip of a DBS lead. This design 
also implemented a ‘shut-off’ timer at 1ms by counting multiple TDC cycles during stimulation. This 
was a protection against damaging protocols, unintended state programming, or improper start-up. We 
also implemented a higher current variant of the Stim IC where the reference current generator (Fig. 
2b) was scaled by a factor of 5, resulting in output current levels ranging from 250 µA to 2mA with 
250µA increments. These current levels are comparable to chronically implanted commercial 
stimulators which must account for increased stimulation thresholds due to fibrotic or glial scarring, or 
reduced proximity to the nerve. The high current variant utilized the same mote design featured in 
Supplementary Fig. 2. 
Design of the external transceiver: The external transceiver was a compact device designed to be 
held by a user with its ultrasonic transducer head placed against the skin of a subject. A previous version 
demonstrated that the external transceiver could also be configured as a wearable device with a low-
profile transducer40. The transceiver established an ultrasonic wireless link with the mote to provide 
power, control stimulation parameters via time-coded downlink data, and report back whether the mote 
had successfully applied each stimulation pulse via detecting backscatter modulation. It was designed 
around two major components: a high-performance microcontroller (NXP LPC4370) for system 
control and digital modulation / demodulation, and a custom ultrasound interface IC102. Due to the 
relatively low frequencies used, a full-digital transceiver was implemented with direct digital synthesis 
of the transmit signal and digitization of the raw receive signal, enabling greater modulation / 
demodulation design flexibility. 
Signal flow through the transceiver is depicted in Fig. 2. A stimulation protocol was programmed into 
the system and stored in a stimulation table as a sequence of A, W, G, S duration values for each 
stimulation event. This table could store up to 4500 unique stimulation events of differing parameters 
and is repeated. An on-board PLL generated a 1.85 MHz square wave carrier signal. On-board timers 
utilized the stimulation table data to encode the downlink timing with on-off keying onto the carrier 
signal with sub-microsecond resolution. The ultrasound interface IC used a high-voltage rail provided 
by an external power supply (5 to 36 V) to level-shift the low voltage transmit signal from the 
microcontroller to a high-voltage signal used to drive the external piezoelectric ultrasound transducer. 
Two different ultrasound transducers could be alternately used: one for interfacing with motes at 
shallow depth (12.7 mm diameter, 21.6 mm focal length, V306-SU-F0.85IN-PTF, Olympus NDT, 
Waltham MA), and one for interfacing with deep motes (25.4 mm diameter, 47.8 mm focal length, 
V304-SU-F1.88IN-PTF). For in vivo tests using these commercial, metal-encased transducers, a thin 
sheet of latex was stretched over the transducer face and castor oil was used as coupling between the 
transducer face and the latex. This prevented electrical paths from the stimulation site to external 
transceiver ground through the transducer casing. The electromechanical frequency response of the 
transducer filtered the square wave transmit signal resulting in a sinusoidal acoustic-domain signal. A 
single-element external transducer was chosen due to the ease and selection of commercial-off-the-
shelf options. Depending on the clinical use case, a wearable external transceiver with a multi-element 
low-profile external transducer, as demonstrated in40, may enable more convenient long-term 
stimulation and beamforming for fine-tuning of the beam axis relative to the mote position103. In 
clinical use-cases where the ultrasonic link is to be maintained for long durations, an ultrasound-
transmissive pad104 or adhesive layer105 could be used in place of ultrasound gel for coupling. Any 
transmission inefficiencies through this coupling layer could be offset by increased transceiver transmit 
power. 
During UFIs (states A and G), the ultrasound interface chip switched from transmit (Tx) to receive 
(Rx) mode to pick up the backscattered signal captured by the external transducer. The receive signal 
was band-pass filtered and amplified (LT6203) by 4.8 dB. A 12-bit ADC on the microcontroller 
digitized the receive signal at 17 MSPS. The digitized backscatter was broken into two regions based 
on the timing values of the downlink modulation signal. The first backscatter region, xS,n-1, was captured 
immediately after the transceiver Sn-1 to An transition and had a duration of twice the acoustic time-of-
flight (TOF) between the external transducer and the mote (~ 20 μs to 60 μs depending on mote depth). 
This corresponded to the duration when the external transducer was no longer driven, but the acoustic 
wave was still travelling to and reflecting off the mote. The xS,n-1 region had an amplitude dependent 
on the mote modulation state during the mote S period, which corresponded to the mote Mmod off. The 
second backscatter region, xW,n, was captured immediately after the transceiver Wn to Gn transition and 
also had a duration of two TOF. This region had an amplitude dependent on the mote modulation state 
during the mote W period. When the mote was properly stimulating, Mmod was on during this region, 
otherwise Mmod was off. When turned on, Mmod reduced the electrical impedance seen by the mote 
piezo (Supplementary Fig. 1), reducing the amplitude of the backscattered wave. 
To detect the modulation or uplink data for each pulse n (dn), the normalized difference between the 
time-integrated amplitudes (L1 norms) of the xW,n and xS,n-1 backscatter signals were compared to a 
threshold. 
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The normalization canceled out any variation due to downlink power or path loss. With calibration, a 
threshold was determined which separates the backscatter relative difference into “1” bits below the 
threshold and “0” bits above the threshold. Calibration was performed by gathering backscatter for 
both “0” and “1” bits, performing a gaussian fit on each population, and finding the threshold which 
minimized the estimated bit error rate given the population statistics. Either the L1 norm (volt-seconds) 
or the L2 norm (backscatter energy in Joules) could be used for this comparison, but L1 showed slightly 
better separation between backscatter states. This single-bit backscattered data from the mote, which 
signified whether the mote was stimulating or not, was given as feedback to the operator of the 
handheld external interrogator via an LED when the mote was detected as active. The backscatter bit 
and raw backscatter digitized waveforms could also be streamed to a PC via a serial connection for 
further logging and diagnostics, though this was not necessary for normal operation (backscatter data 
presented in the figures came from this offload connection). 
Custom C code was used to program the external transceiver microcontroller. LPCOpen (v2014.05) 
and CMSIS_DSPLIB (v2013) C code libraries from NXP (NXP Semiconductors N.V.) were utilized 
in creating this code. ARM gcc (GNU) and MCUXpresso IDE (10.1.1.606, NXP) were used in 
development, compiling and deployment of transceiver code. The external transceiver collected 
backscatter data and transferred it to a Matlab script (R2017b, Mathworks, Inc) running on a PC which 
coordinated experiments and saved data. 
Characterization of motes in ultrasound gel tissue phantom and in ex-vivo tissue: To assess 
performance of the system, a mote with test leads was placed in ultrasound gel (Aquasonic Clear, 
Parker Labs, Fairfield NJ), either freely-floating or mounted on top of a 700 μm diameter steel rod 
connected to a rotation stage (RP01, Thorlabs, Newton, NJ). Bubbles were removed from all ultrasound 
gel used in this study via centrifugation for 16 minutes at 428 x g to 1052 x g. Ultrasound gel has 
acoustic impedance and attenuation within 0.7% and 1.9%, respectively, of those of water106. An 
electrical load was attached to the mote electrode terminals to mimic tissue electrical properties (series 
3 kΩ and 22 nF were used; note that in-vivo values were RSoln = ~4.54 kΩ and Cdl = ~100 nF). The 
external transceiver was mounted to a computer-controlled 2-axis stage (XSlide, VelMex) with the 
external transducer contacting the gel. Mote parameter encoding and decoding performance were 
assessed at a mote depth of 18 mm using the 12.7 mm diameter external transducer at a transmit voltage 
of 19.4 Vpk-pk. Stimulation, power and backscatter performance were assessed at a mote depth of 48 
mm using the 25.4 mm diameter external transducer at a transmit voltage of 25.6 Vpk-pk. Backscatter 
modulation uplink performance was assessed by determining the separation of demodulated ‘one’ bits 
and ‘zero’ bits. ‘One’ bits were gathered with a fully-powered mote showing a high relative difference 
between the modulation states (Mmod off during Sn-1 and Mmod on during Wn). ‘Zero’ bits were gathered 
by operating a mote slightly underpowered so that stimulation did not occur and there was a low relative 
difference between the modulation states (Mmod off during Sn-1 and Mmod off during Wn). Each 
backscatter experiment consisted of 400 or more pulses. The first and last 20 pulses of data in each 
backscatter experiment were thrown out due to interfering experimenter activity in the vicinity of the 
experiment during initiation and stoppage of the experiment, which caused increased noise. The 
performance of the system at various positions and alignments of the mote in the acoustic link were 
assessed by rastering over the transverse translational and angular offset dimensions at a depth of 48 
mm with the 25.4 mm diameter external transducer. The performance of the system at various depths 
and at high pulse repetition frequency were assessed with the mote on the central axis of the external 
transducer using the 25.4 mm diameter external transducer at a transmit voltage of 31.5 Vpk-pk. The 
external transceiver acoustic field for each transducer was characterized in a separate experiment in a 
water tank using a hydrophone (HGL-0400, Onda, Sunnyvale CA USA) (Fig S3). 
StimDust performance at depth in tissue was assessed by operating the device through fresh ex vivo 
porcine tissue. The posterior compartment of a pig hind leg was positioned between the external 
transducer and the mote, with coupling provided by ultrasound gel. The ultrasonic wireless link passed 
through approximately 1.5 mm of skin, 1 mm of fat, 47.5 mm of musculature, including the 
gastrocnemius and soleus muscles, and 5 mm of gel. 
In vivo extracellular electrophysiological stimulation: All in vivo procedures were performed in 
accordance with University of California-Berkeley Animal Care and Use Committee regulations. 
Wireless stimulation was performed in six animals. Stimulation was confirmed in all animals via visual 
observation of the muscle twitch. Detailed quantitative results were collected for animals C, D, and F. 
For each procedure, a male Long-Evans rat (Charles River, Wilmington, MA) of approximately 300 g 
was anesthetized with 1250 mg/kg ethyl carbamate and placed on an isoflurane vaporizer at 0.5% 
isoflurane and 300 mL/minute flow rate. The skin around the leg was shaved and depilated. A 
semicircular flap incision was made from approximately the midpoint of the tibia to the midpoint of 
the femur, following the curvature of the knee joint. The biceps femoris was longitudinally bisected 
and resected to uncover the sciatic nerve. The fascia holding the sciatic nerve to the underlying 
musculature was removed, but the epineurium was left intact. The area was irrigated with sterile saline 
to ensure good electrical contact between the mote and the nerve. A mote was placed on the nerve 
approximately 4 mm proximal to the bifurcation of the nerve to innervate the limb extremities (Fig. 
1b). While this surgery was not optimized for minimal invasiveness, further practice and refinement of 
the surgical procedure and technique, in addition to development of tailored laparoscopic tools, would 
enable implantation of the mote with a vastly smaller incision. The mote had 5 test leads attached to it 
for data collection purposes (GND, VPz+, VPz-, VDD, Velec) (Fig. 1c). These leads were unnecessary for 
the function of the mote and were used for debugging, recording wired data to compare with the 
wireless readout for characterization purposes, and to standardize the fine-alignment of the acoustic 
link; they provided no power or communication signals to the mote. To ensure that these leads had no 
effect on the performance of the system, they were completely disconnected from all external 
instrumentation during a test trial and no change in system performance was seen. Figures 1b and 1c 
were acquired with a Summit K2 USB microscope camera (OptixCam). Other images were taken with 
a modern consumer smartphone camera. Images were lightly edited for crop, brightness (uniformly 
applied), and contrast (uniformly applied). 
For initial verification of functional stimulation and sweeps of stimulation current and pulse width, the 
surgical site was left open and the external interrogator was mounted such that the external transducer 
face was approximately 20 mm from the mote, with ultrasound gel filling the intervening space. The 
external interrogator was then turned on and chip VDD was measured from test leads on the mote. The 
external interrogator position was adjusted to ensure good fine-alignment with the mote and successful 
stimulation was verified with test leads on the mote. This use of a measure of VDD for fine alignment 
of the mote was used for repeatability between trials but was not necessary for function of the system. 
To verify this, positioning of the external transducer relative to the mote was performed without using 
VDD as an alignment reference and the mote was able to receive enough power to function. The 
backscatter amplitude was also an option to aid in positioning the mote without use of a VDD 
measurement.  
Two penetrating stainless-steel electrodes were placed in the gastrocnemius muscle to capture the 
electromyogram signal (EMG) induced by sciatic nerve stimulation. The EMG signal was amplified 
by 1000X, bandpass filtered at 10 Hz to 3 kHz (DP-304, Warner Instr. Co., Hamden CT), digitized at 
100 kSPS (NI DAQ USB 6001, NI, Austin TX), and collected with Signal Express (v2015, National 
Instruments) software. In one animal (Animal F), EMG recordings were taken from three downstream 
muscles: the medial head of the gastrocnemius, the lateral head of the gastrocnemius, and the tibialis 
cranialis (tibialis anterior in bipeds). 
The external interrogator was programmed to specify a stimulation current, pulse width, and pulse 
repetition frequency. The system was initiated and performed several to tens of stimulation events per 
condition before being set to different stimulation parameters. The pulse repetition frequency was kept 
at a relatively low ~1/3 Hz while generating recruitment curves to prevent muscle fatigue. Stimulation 
of the sciatic nerve elicited compound muscle action potentials (CMAP) across much of the lower leg 
musculature. CMAP amplitudes were calculated from baseline to the first peak. To calibrate the 
stimulation response curve, mote parameters were swept across stimulation current and stimulation 
pulse width dimensions, and baseline-to-peak CMAP amplitudes were calculated to construct a 
recruitment curve. A sweep of pulse repetition frequency was also performed and qualitative muscle 
response recorded. A rare ultrasound downlink decoding error was observed in which the mote 
watchdog timer incorrectly identified a change of ultrasound state, resulting in a stimulation of different 
duration than that specified. These stim pulses were excluded from the recruitment curve analysis (1 
total with animal C, 0 total with animal D, 4 total with animal F).  
To verify that the acoustic link was functional while transmitting through the tissue layer of the animal, 
the experiment was repeated with a closed surgical site (Fig 1d). Excess ultrasound gel was removed, 
the biceps femoris replaced over the nerve and mote, and the skin incision sutured with 6-0 nylon 
suture. With the wound closed, ultrasound gel was applied to the outside of the animal and the external 
interrogator was repositioned with the external transducer in contact with gel so that the distance from 
transducer to mote was 18 mm, with approximately 5 mm consisting of tissue. Downlink, stimulation, 
and uplink performance were then assessed with the fully implanted mote. 
To characterize in vivo telemetry, backscatter modulation was detected as described above. The 
relative difference between the L1 norms of these two regions was calculated for 111 successful in 
vivo stimulation pulses (Fig. 6e left population). The relative difference between the L1 norms of the 
Sn and Sn+1 backscatter regions was calculated for the same 111 pulses (Fig. 6e right population) and 
was used as an estimate of the backscatter when Mmod does not turn on during the W phase (which is 
the case when the mote does not stimulate). 
The results presented in Fig 7 and Fig S1 contain data from 50 sets of trials. An additional 103 sets of 
trials were also taken, including those used to ensure that the system was set up and operating 
properly, those depicted in video S1, and final 'exploratory' sets of trials taken after the data shown in 
the figures. All data for every animal and every trial is available upon reasonable request. 
Data Availability: All data used to draw conclusions are presented in this paper and associated 
Supplementary Information. Raw, pre-analyzed data is available upon request. Figures 5, 6, 7, S1, S3, 
S4, and S5 have associated raw data. 
Computer Code Availability: All code used for programming the external transceiver and for 
analyzing data is available upon request.  
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 Supplemental Information 

Fig. S1 | Backscatter modulation design. a, The measured chip input resistance (RIN) for different current 
stimulation loads. The bottom trace is when the modulation switch is enabled, keeping RIN constant across load. The 
difference between the two lines is the modulation depth for a given load. b, Simulated mote piezo impedance versus 
frequency. At resonance, the piezo has a 4 kΩ impedance. c, Simulated backscatter profile at 10mm based for different 
RIN. 
Fig. S2 | Further miniaturized StimDust mote. a, fabricated further-miniaturized StimDust IC. b, Design of further-
miniaturized mote utilizing the fabricated IC and a piezo of the same dimensions as that in Fig 4. 
Supplementary Section 1: Additional results from characterizing mote performance 
The step response ring-up time of the external transducer was approximately 1 cycle, or 0.56 μs. The 
ring-up time for the external transducer and mote piezo system (full downward link) was approximately 
3.5 cycles or 1.94 μs. The ring-up time for the external transducer, mote piezo, and backscatter capture 
system (full bidirectional link) was approximately 4.5 cycles or 2.5 μs. A pulse-train mode was 
demonstrated by interspersing several pulses of short-duration shorting-phase with a pulse of long-
duration shorting-phase. This yielded a pulse-train every 500 ms, with each train containing 10 pulses 
of 100 μs pulse width occurring every 750 μs. 
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The acoustic beam patterns of the 12.7 mm and 25.4 mm diameter external transducers 
(Supplementary       Fig. 3) were had a focal plane intensity transverse full-width-half-maximum of 
1.6 mm and 1.8 mm,   respectively, and an axial intensity longitudinal full-width-half-maximum of 
14 mm and 17.7 mm.  
Fig. S3 | External transceiver acoustic field and piezo voltage harvest. Characterization of the external transceiver 
acoustic field for two alternate transducers used for shallow (12.7 mm diameter transducer) and deep operation (25.4 
mm diameter transducer). a, transverse beampattern. b, longitudinal beampattern. Data taken in a water tank with 
external transceiver and hydrophone. c, Estimated acoustic intensity as a function of depth for common tissue types 
(25.4 mm diameter external transducer). Red lines indicate the acoustic intensity necessary to operate StimDust.d, 
Effect of parylene encapsulation on mote piezo voltage harvest. 
The power performance of the system was measured for two conditions: benchtop operation at high 
PRF and in vivo operation with a fully implanted mote at low PRF (Supplementary Table 1). VTX and 
Pelectrical into the external transducer were measured at the output of the external power supply used to 
supply the ultrasound interface chip. The external transducer was heavily damped to shorten its impulse 
response and much of the acoustic power generated in the external transducer piezo was dumped into 
the absorptive backing layer, causing the electrical input power to acoustic power at the focal plane 
efficiency to be low. 
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Acoustic domain measurements were made with a hydrophone in water; notably, the hydrophone 
measurements were taken in a separate experiment from mote operation and the acoustic values in table 
1 assume that the mote was positioned at the point of maximal acoustic intensity (this may cause up to 
~20% error). For the in vivo condition, the hydrophone measurements could not be made directly, and 
so expected loss from impedance mismatches and absorption in 2 mm of skin and 3 mm of muscle (54, 
107, 55) was modeled to yield an estimate of acoustic intensity inside the animal. The acoustic power at 
the focal plane (depth of the mote) was integrated over a 1 cm radius circle, which is at least 97% of 
the total power in the focal plane. The face of the mote captured approximately 20% of the acoustic 
power in the focal plane. This was a trade-off that balances minimizing the power coupling sensitivity 
of small transverse misalignments with minimizing the unused ultrasound power radiating into the 
body.  
The acoustic power conversion efficiency (ηacoustic) is defined as the ratio of the electrical power used 
to charge to the mote relative to the acoustic power at the face of the mote piezo. This efficiency 
encompasses the acoustic to electrical power efficiency of the piezo, the rectifier efficiency, and the 
standby power consumption of the IC. It was calculated from the measured rate of change of the Cstore 
capacitor voltage (VDD) during initial mote power-up for a 3V VDD steady-state. Under a given incident 
acoustic power, the ηacoustic (as measured by P into Cstore) peaked at ~8.1% when VDD was near half the 
steady-state voltage (Fig. 6f, Supplementary Fig. 4). The mote’s stimulation power (Pstimulation_delivered) 
was calculated by measuring the voltage across an electrode model load. The electrode load was 
modeled as a solution resistance (Rsoln) and double-layer capacitance (Cdl) in series. Rsoln and Cdl were 
discrete passives for the benchtop test; in vivo values were estimated from the stimulation voltage at 
known current output by using the initial IR drop and initial slope of capacitive charging. Qpulse (charge 
per pulse), Epulse, and Pstimulation_delivered were calculated from the measured stimulation voltage 
waveform, Rsoln, Cdl, and fstim. Pstimulation_available was calculated from Qpulse delivered, the voltage 
headroom available, and fstim. Pstimulation_delivered represents the power delivered to the electrode model 
used (and would change with load) while Pstimulation_available represents the maximum stimulation power 
available for any load.  
Note that at low PRF the total Pstimulation_delivered was low and the device charged up quickly and remained 
‘idle’ for most of the time between stimulation pulses yielding a low overall efficiency. Under low PRF 
conditions, it was shown that the device could be intermittently powered up for each pulse to reduce 
the overall ultrasound dose. If optimized for this application, the mote could have a small Cstore to 
reduce startup time.  
      Table S1: System power performance 
* these power values were derived based on the incident acoustic power at the mote face and the measured efficiencies
at various VDDs.  
Supplementary Section 2: Supplementary in vivo results 
Benchtop 
high PRF 
example
In vivo
low PRF 
example
Acoustic medium ultrasound gel gel, skin, muscle
Mote depth from ext. txdr 48 mm 18 mm
Specified PRF 2380 Hz .222 Hz
Specified stim current 400 μA 400 μA
Specified stim pulse width 72 μs 172 μs
Specified interphase gap 10 μs 80 μs
External transducer 25.4 mm Ø 12.7 mm Ø
VTX 28.9 V 24.8 V
U/S duty cycle with UFI's 76% 100%
Pelectrical drive ext. txdr 2.0 W 1.34 W
ISPTA derated 723 mW/cm2 713 mW/cm2
Pacoustic at surface over txdr face 20.9 mW 17.7 mW
Pacoustic at focal plane in 1 cm radius 20.8 mW 14.6 mW
Pacoustic on mote piezo face 4.3 mW 2.8 mW
Mote Cstore 4 μF 4 μF
VDD steady state 1.9 V 3.0 V
P into Cstore average 147 μW* 9.7 μW
ηacoustic_mote_Face -> electrical_VDD 3.4%* 0.34%
ηacoustic_at_surface -> electrical_VDD 0.70% 0.06%
Load Rsoln (est. for in vivo ) 3 kΩ 4.4 kΩ
Load Cdl (est. for in vivo ) 22 nF 100 nF
Qpulse 24 nC 43.4 nC
Epulse 37 nJ 108 nJ
Pstimulation_delivered 89 μW 24 nW
Pstimulation_available 103 μW 30 nW
Mote
External transceiver
Stimulation protocol
Load
Fig. S4 | In vivo power harvesting performance during initial power-up. a, After 4.2 s without receiving power, 
the mote VDD (V across Cstore) was ~0.7 V. When downlink power resumed (at t = 0), the 4 μF Cstore charged over 
~300ms. b, The charging waveform from (a) was used to estimate the efficiency during charging as VDD passed 
through various regimes. ηacoustic is the ratio of electrical power used for charging the mote to acoustic power at the 
face of the mote piezo. At 1.2 VDD, the rate of electrical power harvest was maximum but VDD was below the POR 
cutoff and the device did not stimulate. Between 1.9 VDD and 3.0 VDD, the mote was able to stimulate. Power harvest 
efficiency was moderate at 1.9 VDD and decreased to very low values at 3.0 VDD, which was the point where Cstore 
was nearly topped off and ‘trickle charging’ under the given incident acoustic power conditions. 
Figure S5 | Precise control of evoked neural response achieved through varying stimulation current or 
stimulation pulse width, second sweep of parameters: This data was taken with the same animal and mote as that 
in Fig. 7, but 2 hours after the first sweep. See Fig. 7 for panel descriptions. 
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Figure S6 | Supplementary in vivo results: Animals C and F: a, EMG trace of stimulation that was performed in 
Animal C with the ultrasonic link traversing muscle and skin layers between the implantation site and the exterior of 
the body. b, c, StimDust operation in animal C at stimulation pulse duration values between 22 μs and 292 μs, with 
sigmoidal EMG recruitment. d, e, StimDust operation in animal F at stimulation current values between 50 μA and 
400 μA, with sigmoidal EMG recruitment. f-k, StimDust operation in animal F at stimulation pulse duration values 
between 22 μs and 392 μs, with sigmoidal EMG recruitment across three innervated muscles. 
Video S1 | In vivo neural stimulation with fully implanted wireless StimDust. Example stimulation 
pulses delivered at 0.22 Hz. In clips (a) and (b) (animal D), the animal’s right hindquarters are visible 
with cranial to the right and caudal to the left. The closed surgical site is at the center of the frame and 
the animal’s right leg and foot are towards the bottom left of the frame, with two EMG electrodes 
visible. The external transducer can be seen at the top of the frame. Ultrasound gel fills the gap between 
the external transducer and the animal, and a glass slide makes this space visible. Clip (c) shows a view 
from the rear (animal D). Clip (d) shows a different experiment with the mote implanted on the left 
sciatic (animal C). 
Supplementary Section 3: Discussion supporting the claim that stimulation was due to the mote 
output current and was not directly ultrasound mediated 
At 1.85 MHz, the threshold of ultrasound-mediated neural stimulation has been reported at 
approximately 10 W/cm2 pulse-average intensity108; this is more than 14x higher intensity than that 
used in this study. Furthermore, as the system increased stimulation current from 50 μA to 400 μA with 
a corresponding recruitment of CMAP response, acoustic power was nearly identical and actually 
decreased slightly since the protocol utilizes a longer TDC gap when specifying high current. 
Additionally, no EMG response was observed when the system was driven with continuous ultrasound 
at the same intensity as used for controlling the device, but with no coded downlink signals. Finally, a 
pilot in vivo experiment, which powered the mote electrically with no ultrasound, produced stimulation 
and evoked CMAP’s identical to those evoked with an acoustically-powered mote (data not shown). 
Utilizing a current-control implantable stimulator provides improved stimulation precision and spatial 
resolution as compared to directly mediated ultrasonic stimulation, and requires substantially lower 
acoustic intensities and thus has lower risk from ultrasound-induced thermal or cavitation damage109.  
Electrodes Characterization: 
Figure S7 | Stimulation electrodes characterization in saline: a, b, c, d, e, f, The electrode voltage during 
stimulation pulses was measured for two devices before and after PEDOT:PSS plating. Each device that was tested 
was an inactive mote which had stim electrode and ground testing leads connected to the corresponding testing leads 
of a functional mote that was acoustically driven and provided the stimulation current pulses. g, Impedance spectrum 
before and after PEDOT:PSS plating (device 1). 
Supplementary Section 4: Discussion of monophasic stimulation 
StimDust adopts a design with monophasic stimulation and charge balance via electrode shorting (also 
known as passive recharge). This enables operation with a single power supply, saving area, power, 
and complexity on the volume- and power-constrained wireless device. This passive charge-balancing 
approach has been used successfully in clinical stimulators; Parastarfeizabadi and Kouzani 2017110 
write: “most of the available market-based open-loop and closed-loop DBS systems use a passive 
charge-balancing scheme.” The passive charge balance leads to a discharge current as the remaining 
charge stored at the electrode interface flows through the tissue solution resistance during the shorting 
phase. Unlike many monophasic stimulators, StimDust has bipolar electrodes in close proximity and 
of identical area. As such, there is no asymmetry in current density at the electrodes, as there is for a 
monopolar stimulator which utilizes, for example, the large surface of an implanted titanium can as the 
 that this charge-balance current does not present any danger to the tissue,            return electrode. To ensure
the tissue interface was 
modeled. 
Figure S8 | Monophasic stimulation and charge balancing: a, simplified stimulator model (model A) with a simple 
electrode model: Cdl - Rs – Cdl. Rf,s and Rf,r are ignored in this model. b, 50 μA, 392 μs pulse fit to empirical data 
from animal D (parameters 95 nF, 4.4 kOhm). c, 300 μA, 392 μs pulse fit to empirical data from animal D (parameters 
222 nF, 4.7 kΩ). d, simplified stimulator model (model B) with R1∥C1 - R2∥C2 - Rs - R2∥C2 - R1∥C1 electrode 
model. e, 50 μA, 392 μs pulse fit to empirical data from animal D (parameters 300 Ω, 40 nF, 8.6 kΩ, 65 nF, 4.2 kΩ). 
f, 300 μA, 392 μs pulse fit to empirical data from animal D (parameters 350 Ω, 55 nF, 6.0 kΩ, 190 nF, 4.4 kΩ). g, 
sweep of stimulation pulse duration from 100 μs to 600 μs (parameters: same as in f). 
To model this, two circuits were simulated, each with a pulsed current source, an electrode-tissue 
equivalent circuit, and a shorting switch with shorting resistance (Fig S7). Stimulation current was 
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applied for the (W) stim width phase; the electrodes were in a high-impedance state for the (G) 
interphase gap; and the shorting switch was closed for the (S) shorting phase. The resistance along the 
shorting path in the mote IC (Rshort) is 130 Ω (the on-resistance of the shorting NMOS transistor in 
Fig.3b). This reduces the maximum charge balance current and is independent of the tissue solution 
resistance. In model A, the electrode-tissue equivalent circuit is simplified to just a double-layer 
capacitance Cdl at each electrode, and a solution resistance Rsoln. This model is not perfect at fitting the 
shape of the stimulation pulse, but is widely used and easy to analyze. Model B considers a R1∥C1 - 
R2∥C2 at each electrode, with a solution resistance Rsoln in between. This equivalent circuit has been 
shown to fit the behavior of neural stimulating electrodes111. It avoids an explicit constant phase 
element, as seen in some electrode impedance models which are analyzed only in the frequency 
domain112, because these elements take more parameters (RC elements) to model in the time domain113. 
Initial estimates of parameter values were generated using Zfit114 on impedance spectroscopy data in 
PBS. Parameter estimates were then adjusted in a time-domain SPICE model to both peg the simulated 
electrode voltage at the end of the interphase gap to the empirical data from animal D and to fit the 
shape of the stimulation voltage as closely as possible. Through this fitting process, there was some 
variability or uncertainty in capacitor values, but little uncertainty in the series solution resistance. The 
maximum charge balance current depends almost entirely on the electrode voltage at the end of the 
interphase gap and the series solution resistance. The former is known empirically and the latter has a 
confident modeled value. Therefore, the estimates for maximum charge balance current are good. The 
estimates for the charge balance current time constant are slightly less certain due to lower confidence 
in the correct modelling of capacitive effects at the electrode interface. 
Table S2: Charge balance current values from empirically pegged and fit simulations of the stimulation pulse. The 
first set of simulations with model A use parameters from the range of fit parameters which yield maximal peak charge 
balance current. The second set of simulations with model A use parameters from the range of fit parameters which 
yield maximal discharge time. 
Simulations were run and the charge balance current was measured, with key values extracted (Table 
S2). The simulations were performed with a stimulation pulse duration of 392 μs. This was the longest 
pulse duration utilized by StimDust, and is in the ‘saturation’ region of the recruitment curve by 
stimulation duration (Fig 7f). Peak charge balance current varies roughly linearly with stimulation pulse 
duration (Fig S7d), so pulses with duration less than 392 μs will have charge balance current values 
lower than those reported in Table S2.  
Taken together, the data in Table S2 show that peak charge balance current never exceeds 251 μA, well 
below the nominal maximum stimulation current of 400 μA. Furthermore, the amount of time before 
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A 100 nF, 4.4kΩ 50 83 167% 116 1344
A 100 nF, 4.4kΩ 100 131 131% 61 1447
A 100 nF, 4.4kΩ 150 162 108% 18 1495
A 100 nF, 4.4kΩ 200 162 81% 0 1495
A 100 nF, 4.4kΩ 250 185 74% 0 1524
A 100 nF, 4.4kΩ 300 211 70% 0 1555
A 100 nF, 4.4kΩ 350 228 65% 0 1572
A 100 nF, 4.4kΩ 400 245 61% 0 1588
A 250 nF, 4.8 kΩ 50 77 153% 263 3657
A 250 nF, 4.8 kΩ 100 131 131% 167 3936
A 250 nF, 4.8 kΩ 150 162 108% 48 4066
A 250 nF, 4.8 kΩ 200 162 81% 0 4068
A 250 nF, 4.8 kΩ 250 185 74% 0 4147
A 250 nF, 4.8 kΩ 300 211 70% 0 4230
A 250 nF, 4.8 kΩ 350 228 65% 0 4278
A 250 nF, 4.8 kΩ 400 245 61% 0 4321
B 300 Ω, 40 nF, 8.6 kΩ, 65 nF, 4.2 kΩ 50 89 179% 52 729
B 300 Ω, 40 nF, 7.6 kΩ, 90 nF, 4.3 kΩ 100 137 137% 28 1068
B 300 Ω, 40 nF, 6.6 kΩ, 110 nF, 4.3 kΩ 150 172 115% 10 1304
B 325 Ω, 55 nF, 6.6 kΩ, 165 nF, 4.3 kΩ 200 174 87% 0 1969
B 330 Ω, 55 nF, 6.3 kΩ, 185 nF, 4.3 kΩ 250 197 79% 0 2230
B 350 Ω, 55 nF, 6.0 kΩ, 190 nF, 4.4 kΩ 300 221 74% 0 2352
B 350 Ω, 55 nF, 6.0 kΩ, 215 nF, 4.4 kΩ 350 236 67% 0 2676
B 350 Ω, 55 nF, 6.0 kΩ, 235 nF, 4.4 kΩ 400 251 63% 0 2957
charge balance current falls below the nominal stimulation current is substantially less than the 
stimulation pulse duration. All of these values would be less for shorter pulse durations. Importantly, 
most literature reporting the threshold for tissue damage is closely linked to charge per phase and 
charge density per phase115. The total charge transferred during the charge-balance phase is necessarily 
less than or equal to that during the stimulation phase. Stimulation protocols used in this work are 
plotted against the Shannon equation in Figure S9. 
Figure S9: Charge (Q) vs. charge density (Q/A) for safe stimulation limits using k = 1.7. Data below the k = 1.7 line 
predict safe operation. The largest stimulation pulse used in this work is 40% of the limit.  
The Shannon equation incorporates pulse width, current, and electrode area, but does not directly 
account for short, high intensity current pulses which can accompany passive recharge. Butterwick et. 
al. 2007 mapped the strength-duration dependence of damage thresholds for retinal cells. Assuming a 
damage threshold of 1mA/cm2, we estimated Rsoln for square electrodes in vivo and in saline for various 
areas to determine the backrush current density (Jbackrush). We assumed a bipolar, symmetric electrode 
configuration and that the maximum stored electrode voltage was 1.2V (Figure S10). 
Figure S10: Backrush current density vs. square electrode area in saline and in tissue. As the stimulation and 
return  electrodes scale to smaller, the discharge current can exceed the 1A/cm2 damage threshold. The 
diamond represents the maximum discharge current for this work. 
